All patients list_Shirotake et al_Molecular and Clinical Oncology 2018.xlsx

A list of the clinical and pathological data of 209 patients
with advanced renal cell carcinoma (with or without metastasis) treated with molecular targeted therapy between April
25, 2008 and February 27, 2017 in Saitama Medical University International Medical Center. These patients in this list were automatically isolated from electronic
medical records using the terms “sorafenib”, “sunitinib”, “axitinib”,
“pazopanib”, “temsirolimus”, “everolimus”, “renal tumor”, and “renal cell
carcinoma”. The analyses of this data is published in Molecular and Clinical Oncology.